HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $859,510 | -39.6% | 569,212 | 0.0% | 0.01% | -36.8% |
| Q4 2022 | $1,423,030 | -57.7% | 569,212 | -28.7% | 0.02% | -59.6% |
| Q3 2022 | $3,367,000 | +47.5% | 797,906 | -2.5% | 0.05% | +34.3% |
| Q2 2022 | $2,283,000 | -29.9% | 818,162 | +43.8% | 0.04% | -34.0% |
| Q1 2022 | $3,256,000 | -36.1% | 569,155 | +2.0% | 0.05% | -27.4% |
| Q4 2021 | $5,093,000 | – | 557,799 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |